InvestorsHub Logo

DR5

Followers 10
Posts 1100
Boards Moderated 0
Alias Born 01/05/2018

DR5

Re: 59SC post# 3618

Friday, 10/18/2019 8:48:58 PM

Friday, October 18, 2019 8:48:58 PM

Post# of 13601
Nice pickup bro! To me...today was THE most exciting day for this investment! I know we have the approval and buyout coming but for me the human trial result could not have been better.
From all my years as an executive in pharma, I look at this trial from a purely clinical standpoint. I’ve studied thousands of clinical trials in my career and everything about the trial and results says FDA approval to me.
1. Quality of the investigators
2. Study design:
- WIRB
- patient selection
- head to head vs. SurgiCel (current standard of care
- positive outcomes on primary and secondary endpoints including non-inferiority AND superiority.

Folks, it doesn’t get any better than this. HemoStyp WILL get the class 3 approval. I couldn’t be more certain of that outcome!

We will all be celebrating for a very long time!

Cheers and have a great weekend friends!